IP Library Granted Patent US 8,084,228
Granted Patent B2
US 8,084,228 · App. 12/087,435 · Granted Dec 27, 2011

Nogo-B receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,228
App. No.
12/087,435
Granted
Dec 27, 2011
Kind
B2
Abstract

Nogo-B receptors bind to Nogo-B and mediate its biological function. We have discovered that Nogo-B receptor is a component of endothelial cells, and is highly expressed in intact blood vessels. The present invention provides compositions comprising the Nogo-B receptor and fragments and fusion proteins thereof. The present invention also relates to nucleic acids encoding the Nogo-B receptor and fragments and fusion proteins thereof, as well as vectors and cells comprising such nucleic acids. The present invention also relates to antibodies specific for the Nogo-B receptor and fragments and fusion proteins thereof. The present invention also provides methods for preventing, detecting and treating Nogo-B receptor-related diseases, disorders and conditions.

Claims (12)

1. A composition comprising a fragment of a Nogo-B receptor that inhibits a biological activity of a Nogo-B receptor, wherein said fragment consists of residues 52-116 of SEQ ID NO: 1.

2. A fusion protein comprising a fragment of Nogo-B receptor and a heterologous protein component, wherein said fragment consists of residues 52-116 of SEQ ID NO: 1.

3. A nucleic acid molecule comprising a nucleotide sequence encoding the fusion protein of claim 2 .

4. A vector comprising the nucleic acid molecule of claim 3 .

5. A host cell comprising the nucleic acid molecule of claim 3 or the vector of claim 4 .

6. A method for producing a fusion protein, wherein said fusion protein comprises a fragment of Nogo-B receptor consisting of residues 52-116 of SEQ ID NO: 1, said method comprising culturing the host cell of claim 5 under suitable conditions in media so that the host cell produces the fusion protein and isolating the fusion protein.

7. A composition comprising a fragment of a Nogo-B receptor that inhibits a biological activity of a Nogo-B receptor, wherein said fragment consists of the amino acid sequence of SEQ ID NO: 14, SEQ ID NO: 16, or SEQ ID NO: 18.

8. A fusion protein comprising a fragment of Nogo-B receptor and a heterologous protein component, wherein said fragment consists of the amino acid sequence of SEQ ID NO: 14, SEQ ID NO: 16, or SEQ ID NO: 18.

9. A nucleic acid molecule comprising a nucleotide sequence encoding the fusion protein of claim 8 .

10. A vector comprising the nucleic acid molecule of claim 9 .

11. A host cell comprising the nucleic acid molecule of claim 9 or the vector of claim 10 .

12. A method for producing a fusion protein, wherein said fusion protein comprises a fragment of Nogo-B receptor consisting of the amino acid sequence of SEQ ID NO: 14, SEQ ID NO: 16, or SEQ ID NO: 18, said method comprising culturing the host cell of claim 11 under suitable conditions in media so that the host cell produces the fusion protein and isolating the fusion protein.